Karyopharm Therapeutics Inc. – Underwriting Agreements – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Underwriting Agreements Filter

from SCHEDULE 13G 1 page Joint Filing Agreement

from S-3 44 pages Open Market Sale Agreementsm

from SC 13G 1 page Exhibit 1 Joint Filing Agreement

from 8-K 42 pages Karyopharm Therapeutics Inc. (A Delaware Corporation) 6,250,000 Shares of Common Stock Underwriting Agreement

from 8-K 39 pages Karyopharm Therapeutics Inc. (A Delaware Corporation) 9,152,543 Shares of Common Stock Underwriting Agreement

from 8-K 38 pages Karyopharm Therapeutics Inc. (A Delaware Corporation) 3,902,439 Shares of Common Stock Underwriting Agreement

from 8-K 46 pages Karyopharm Therapeutics Inc. Shares of Common Stock (Par Value $0.0001 Per Share) Controlled Equity Offeringsm Sales Agreement

from 8-K 46 pages Karyopharm Therapeutics Inc. (A Delaware Corporation) 3,000,000 Shares of Common Stock Underwriting Agreement

from S-1/A 38 pages Karyopharm Therapeutics Inc. (A Delaware Corporation) [ ] Shares of Common Stock Underwriting Agreement

from S-1/A 31 pages Karyopharm Therapeutics Inc. (A Delaware Corporation) · Shares of Common Stock Underwriting Agreement